Feature articles during July focused on global regulatory strategy for cell and gene therapy, with articles on US and EU regulations and guidances and the development and manufacture of the therapies. Also included were articles on recasting the corrective and preventive action (CAPA) process as a continuous improvement process, a military-civilian perspective on real-world evidence (RWE) to support regulatory decision making, and regulatory reporting in multinational trials during COVID-19.Advanced therapy medicinal products (ATMPs), including cell therapies, gene therapies, and tissue-engineered products, are highly complex treatments that differ from traditional medicines, both in how they are made and administered and in the benefits they may provide. Regulations for these products were established relatively recently and are still evolving in many jurisdictions globally. The novelty of these products, the inherent complexities of cell and gene therapy products, and the lack of experience with such products pose many challenges for developers.In part one of this two-part series, this months expert authors address these challenges and offer hands-on, practical advice and guidance on regulation and production of ATMPs. If there is one clear, take-home message to developers, it is that early and frequent collaboration with regulatory agencies, during both the approval and development phases, is paramount. It saves time and money, and it reduces the risk of a negative impact on the trajectory of a clinical trial. Part 2 of the series will cover upstream manufacturing and process controls for biologics, the ATMP regulatory landscape in China, EU GMP requirements for autologous cell therapies and parenteral biologics, and regulatory challenges and opportunities in the US.Regulations and guidancesThe regenerative medicine advanced therapy (RMAT) field has the potential to provide profound benefits to patients with serious diseases and disorders, and the RMAT designation is helping drive these transformative technologies to market. In Update on RMAT designations, William K. Sietsema and Janet Lynch Lambert discuss the scope and purpose of the special designation for RMATs created by the passage of the 21st Century Cures Act and provide a tally of products that have received the special designation to date. However, while the promise of regenerative medicines to cure disease is propelling the field at a rapid pace, developing these therapies requires a rigorous, carefully planned approach to ensure a seamless progression to regulatory approval and commercial success.Siegfried Schmitt expands on that point about carefully navigating the complex and nuanced regulatory environment in two articles on US and EU regulations for RMATs and ATMPs, respectively. In US regulations for regenerative medicine advanced therapies, he provides a user-friendly, quick-access list of RMAT-related regulations and guidances. The article includes a useful introduction to the application process and descriptions of the features and criteria for various expedited program options, including breakthrough therapy, fast track, advanced approval, and priority review.In Regulation of advanced therapy medicinal products in the EU, Schmitt explains some of the terminology relating to ATMPs before documenting the key EU regulations and guidances for each therapy type. He concludes with discussions on marketing authorization, accelerated regulatory pathways, and market access. Again, he urges companies and developers to engage with the regulatory agencies early and often throughout the approval process and to seek external regulatory support, especially if the developer has limited in-house regulatory resources.Development pathways and manufacturingTwo articles shift the focus from the regulatory landscape to development and manufacturing pathways. The drug manufacturing facility environment presents one of the major sources of potential contaminants in the final biologic drug product, so it is critical to design facilities with cleanroom environmental controls and monitoring that adhere to the highest standards of current good manufacturing practice (cGMP) quality guidelines, write Mo Heidaran and colleagues. In Designing a biologics manufacturing facility: Early planning for success, the authors lay out the planning steps for compliance with cGMP to readiness for chemistry, manufacturing, and controls (CMC). The authors warn that the pressure to reduce time to market put considerable stress on all aspects of commercial operations and commercial-scale manufacturing development, so yet again, early tactical and strategic planning essential.In Advanced therapies: Trip hazards along the development pathway, Kirsten Messmer and Richard Dennett focus on the challenges and complexities of ferrying advanced therapies along the developmental pathway, which they call the trip. They examine the importance of some of the fundamental building blocks for the development program and highlight some commonly encountered challenges, or trip hazards, for cell and gene therapies. The suggest developers establish sound technical and regulatory strategies to better anticipate and avoid the trip hazards, which could prove costly, both in time and money, and have a negative impact the overall clinical study program.CAPA, RWE, and COVID-19Todays CAPA process has become highly focused on compliance, which has manufacturers struggling to determine which issues require a structured CAPA process and which can be resolved in alternative ways, writes Kathryn Merrill in Recasting CAPA as a continuous improvement process. Merrill summarizes a white paper developed by the Medical Device Innovation Consortium, in which the CAPA process is recast as a continuous improvement process for driving higher product quality and improved patient safety. It is intended to enable organizations make a greater number of improvements more quickly, and over time, which will have a favorable impact on product quality in the field.During the Afghanistan and Iraq wars, the US Military Health System used an approach known as focused empiricism to develop new approaches for casualty care. In doing so, it implemented real-world data (RWD) and RWE into a system of performance improvement and product development to achieve historic rates of survival, write Todd E. Rasmussen, a colonel in the US Air force, and Brian J. Young. In A military-civilian perspective on real-world evidence to support regulatory decision making, the authors summarize the framework promoting the collection and analysis of RWD in the healthcare system and describe a new era of collaboration between the US Department of Defense and the FDA, within the context of a new Public Law 115-92, to coordinate on the delivery of military-relevant medical products. The article reviews the FDA evidentiary standards for medical product approval and gives examples of how RWE can help meet those standards.COVID-19 continues to disrupt and redefine the regulatory process and activity. In Managing uncertainty: Regulatory reporting in multinational trials during COVID-19, Ioana Ionita discusses regulatory reporting challenges for multinational clinical trials during the pandemic, as well as the challenge of assessing what is reportable and how to submit COVID-19 risk mitigation measures. She offers real-world experience on how she and her colleagues stopped and restarted recruitment in ongoing multinational clinical trials, and how those actions were reported globally. Ionita concludes that close collaboration between sponsors, CROs, local affiliates, investigational sites, and health authorities is important in choosing strategies under challenging circumstances and when no precedent applies.Whats coming in August?Articles during August will focus on global clinical trials and clinical trial applications. Despite ICH efforts to produce guidelines for the development of drugs and biologics and to standardize the format of marketing applications, there remain considerable differences among countries in the format of clinical trial applications and health authority review processes. This collection of articles will address these divergent formats and processes and provide options for navigating the regulatory aspects of clinical trials. Look for these topics and more throughout August at http://www.raps.org.October call for articlesFor October, Regulatory Focus will look at the regulatory toolboxthe tools regulatory professionals need and where to find them, with an emphasis on websites, guidances, meeting minutes and FDA correspondence, including warning letters, enforcement actions, 483s, and notices. Articles will discuss how to interpret the meaning behind regulatory agency actions and available options for documentation. The submission deadline for articles is 1 September 2020. To contribute to the October issue or suggest a topic, contact Rene Matthews at rmatthews@raps.org.Citation Matthews R. Regulatory Focus, July issue: Cell and gene therapy. Regulatory Focus. July 2020. Regulatory Affairs Professionals Society.
More here:
Regulatory Focus, July issue: Cell and gene therapy - Regulatory Focus
- About the Gene Therapy Review [Last Updated On: November 8th, 2009] [Originally Added On: November 8th, 2009]
- Contribute an Article [Last Updated On: November 8th, 2009] [Originally Added On: November 8th, 2009]
- EBSCO Publishing Deal [Last Updated On: November 8th, 2009] [Originally Added On: November 8th, 2009]
- Advertising Opportunities [Last Updated On: November 8th, 2009] [Originally Added On: November 8th, 2009]
- Instructions for Authors [Last Updated On: November 8th, 2009] [Originally Added On: November 8th, 2009]
- Isis Collaboration With Ortho-McNeil Inc for Metabolic Diseases [Last Updated On: November 8th, 2009] [Originally Added On: November 8th, 2009]
- Dystrophin Gene Transfer safe in Duchenne muscular dystrophy [Last Updated On: November 8th, 2009] [Originally Added On: November 8th, 2009]
- Researchers Identify Gene for Rare Form of Spinal Muscular Atrophy [Last Updated On: November 8th, 2009] [Originally Added On: November 8th, 2009]
- Fatal brain cancer tamed by New gene therapy [Last Updated On: November 8th, 2009] [Originally Added On: November 8th, 2009]
- Gene therapy effective in fighting obesity in mice [Last Updated On: November 8th, 2009] [Originally Added On: November 8th, 2009]
- Genzyme gene therapy for people with peripheral artery disease failed in a clinical trial to help them regain some mobility [Last Updated On: November 8th, 2009] [Originally Added On: November 8th, 2009]
- Gene Therapy May Stall Inherited Emphysema [Last Updated On: December 31st, 2009] [Originally Added On: December 31st, 2009]
- Gene Therapy and Stem Cells Save Limb [Last Updated On: December 31st, 2009] [Originally Added On: December 31st, 2009]
- Faulty Circuits (preview) [Last Updated On: August 17th, 2024] [Originally Added On: April 7th, 2010]
- Rare flowers and common herbal supplements get unmasked with plant DNA barcoding [Last Updated On: August 17th, 2024] [Originally Added On: April 20th, 2010]
- Biomarker Studies Could Realize Goal of More Effective and Personalized Cancer Medicine [Last Updated On: August 17th, 2024] [Originally Added On: April 27th, 2010]
- Schizophrenia shares genetic links with autism, genome study shows [Last Updated On: August 17th, 2024] [Originally Added On: May 12th, 2010]
- Alzheimer's: Forestalling the Darkness with New Approaches (preview) [Last Updated On: August 17th, 2024] [Originally Added On: May 28th, 2010]
- Alzheimer's: Forestalling the Darkness with New Approaches (preview) [Last Updated On: August 17th, 2024] [Originally Added On: May 28th, 2010]
- Large-Scale Autism Study Reveals Disorder's Genetic Complexity [Last Updated On: August 17th, 2024] [Originally Added On: June 12th, 2010]
- Large-Scale Autism Study Reveals Disorder's Genetic Complexity [Last Updated On: August 17th, 2024] [Originally Added On: June 12th, 2010]
- Cancer Therapy Goes Viral: Progress Is Made Tackling Tumors with Viruses [Last Updated On: August 17th, 2024] [Originally Added On: June 24th, 2010]
- Vaccines Derived from Patients' Tumor Cells Are Individualizing Cancer Treatment [Last Updated On: August 17th, 2024] [Originally Added On: June 26th, 2010]
- Vaccines Derived from Patients' Tumor Cells Are Individualizing Cancer Treatment [Last Updated On: August 17th, 2024] [Originally Added On: June 26th, 2010]
- A genome story: 10th anniversary commentary by Francis Collins [Last Updated On: August 17th, 2024] [Originally Added On: June 29th, 2010]
- Hair Trigger: How a Cell's Primary Cilium Functions as a Molecular Antenna [Last Updated On: August 17th, 2024] [Originally Added On: June 30th, 2010]
- Hair Trigger: How a Cell's Primary Cilium Functions as a Molecular Antenna [Last Updated On: August 17th, 2024] [Originally Added On: June 30th, 2010]
- DNA Drugs Come of Age (preview) [Last Updated On: August 17th, 2024] [Originally Added On: July 16th, 2010]
- 2 Genes Linked to Embryonic Brain Impairment in Down's Syndrome [Last Updated On: August 17th, 2024] [Originally Added On: July 22nd, 2010]
- 2 Genes Linked to Embryonic Brain Impairment in Down's Syndrome [Last Updated On: August 17th, 2024] [Originally Added On: July 22nd, 2010]
- Stem Cells from Reprogrammed Adult Cells Found to Bring Along Genetic Defects of Their Donors [Last Updated On: August 17th, 2024] [Originally Added On: October 11th, 2010]
- Was Darwin a Punk? A Q&A with Punker-Paleontologist Greg Graffin [Last Updated On: August 17th, 2024] [Originally Added On: October 11th, 2010]
- Was Darwin a Punk? A Q&A with Punker-Paleontologist Greg Graffin [Last Updated On: August 17th, 2024] [Originally Added On: October 11th, 2010]
- Parkinsonian Power Failure: Neuron Degeneration May Be Caused by a Cellular Energy System Breakdown [Last Updated On: August 17th, 2024] [Originally Added On: October 11th, 2010]
- Desperation Drives Parents to Dubious Autism Treatments (preview) [Last Updated On: August 17th, 2024] [Originally Added On: October 17th, 2010]
- Revolution Postponed: Why the Human Genome Project Has Been Disappointing (preview) [Last Updated On: August 17th, 2024] [Originally Added On: November 7th, 2010]
- Controlling the Brain with Light (preview) [Last Updated On: August 17th, 2024] [Originally Added On: November 7th, 2010]
- Optogenetics: Controlling the Brain with Light [Extended Version] [Last Updated On: August 17th, 2024] [Originally Added On: November 7th, 2010]
- Clear New Insights into the Genetics of Depression [Last Updated On: August 17th, 2024] [Originally Added On: November 7th, 2010]
- TEDMED 2010: Technology and the people [Last Updated On: August 17th, 2024] [Originally Added On: November 7th, 2010]
- Bacteria, the anti-cancer soldier [Last Updated On: August 17th, 2024] [Originally Added On: November 7th, 2010]
- Scientific regress: When science goes backward [Last Updated On: August 17th, 2024] [Originally Added On: February 14th, 2011]
- Can You Live Forever? Maybe Not--But You Can Have Fun Trying [Last Updated On: August 17th, 2024] [Originally Added On: February 14th, 2011]
- How to Fix the Obesity Crisis (preview) [Last Updated On: August 17th, 2024] [Originally Added On: February 14th, 2011]
- Personalizing cancer medicine [Last Updated On: August 17th, 2024] [Originally Added On: February 14th, 2011]
- New Salmonella strain delivers gene-based therapy to fight virus in mice [Last Updated On: August 17th, 2024] [Originally Added On: February 14th, 2011]
- Steps toward a Bionic Eye [Last Updated On: August 17th, 2024] [Originally Added On: February 20th, 2011]
- Giving HIV a Poor Reception: New AIDS Treatment Tinkers with Immune Cell Genes [Last Updated On: August 17th, 2024] [Originally Added On: March 6th, 2011]
- Smaller, cheaper, faster: Does Moore's law apply to solar cells? [Last Updated On: August 17th, 2024] [Originally Added On: March 27th, 2011]
- Smaller, cheaper, faster: Does Moore's law apply to solar cells? [Last Updated On: August 17th, 2024] [Originally Added On: March 27th, 2011]
- New Drugs for Hepatitis C on the Horizon [Last Updated On: August 17th, 2024] [Originally Added On: April 10th, 2011]
- Can we capture all of the world's carbon emissions? [Last Updated On: August 17th, 2024] [Originally Added On: April 10th, 2011]
- Can we capture all of the world's carbon emissions? [Last Updated On: August 17th, 2024] [Originally Added On: April 10th, 2011]
- Drug-resistant genes found in cholera and dysentery strains in New Delhi water supply [Last Updated On: August 17th, 2024] [Originally Added On: May 1st, 2011]
- Fast Track to Vaccines: How Systems Biology Speeds Drug Development (preview) [Last Updated On: August 17th, 2024] [Originally Added On: May 1st, 2011]
- TNVitamins.com – $10 Off Of $50 order [Last Updated On: May 7th, 2011] [Originally Added On: May 7th, 2011]
- 15% Off Any PetAlive Order [Last Updated On: May 7th, 2011] [Originally Added On: May 7th, 2011]
- At PetAlive – $10 off order of $50 or more [Last Updated On: May 7th, 2011] [Originally Added On: May 7th, 2011]
- Native Remedies coupon – 5% Off Any Order [Last Updated On: May 7th, 2011] [Originally Added On: May 7th, 2011]
- Native Remedies – Save $5 coupon [Last Updated On: May 7th, 2011] [Originally Added On: May 7th, 2011]
- Welcome to the Gene Therapy Review [Last Updated On: May 15th, 2011] [Originally Added On: May 15th, 2011]
- Editorial Board [Last Updated On: May 15th, 2011] [Originally Added On: May 15th, 2011]
- Gene Therapy Job Board [Last Updated On: May 15th, 2011] [Originally Added On: May 15th, 2011]
- Corporate Membership [Last Updated On: May 22nd, 2011] [Originally Added On: May 22nd, 2011]
- Native Remedies coupon – 25% Off Any Order [Last Updated On: May 29th, 2011] [Originally Added On: May 29th, 2011]
- What is Gene Therapy? [Last Updated On: June 19th, 2011] [Originally Added On: June 19th, 2011]
- Autism's Tangled Genetics Full of Rare and Varied Mutations [Last Updated On: August 17th, 2024] [Originally Added On: June 19th, 2011]
- Autism's Tangled Genetics Full of Rare and Varied Mutations [Last Updated On: August 17th, 2024] [Originally Added On: June 19th, 2011]
- A New Look at Obsessive-Compulsive Disorder (preview) [Last Updated On: August 17th, 2024] [Originally Added On: June 19th, 2011]
- Close Encounters of Science and Medicine [Last Updated On: August 17th, 2024] [Originally Added On: July 3rd, 2011]
- New Report Details Uphill Battle to Solve the U.S.'s Pain Problem [Last Updated On: August 17th, 2024] [Originally Added On: July 24th, 2011]
- New Report Details Uphill Battle to Solve the U.S.'s Pain Problem [Last Updated On: August 17th, 2024] [Originally Added On: July 24th, 2011]
- A Breath of Fresh Air: New Hope for Cystic Fibrosis Treatment (preview) [Last Updated On: August 17th, 2024] [Originally Added On: August 7th, 2011]
- Studying Mental Illness in a Dish [Last Updated On: August 17th, 2024] [Originally Added On: November 13th, 2011]
- The Puzzle of Pancreatic Cancer: How Steve Jobs Did Not Beat the Oddsbut Nobel Winner Ralph Steinman Did [Last Updated On: August 17th, 2024] [Originally Added On: November 13th, 2011]
- The Puzzle of Pancreatic Cancer: How Steve Jobs Did Not Beat the Odds?but Nobel Winner Ralph Steinman Did [Last Updated On: August 17th, 2024] [Originally Added On: November 13th, 2011]
- Did Alternative Medicine Extend or Abbreviate Steve Jobs's Life? [Last Updated On: August 17th, 2024] [Originally Added On: November 13th, 2011]
- Did Alternative Medicine Extend or Abbreviate Steve Jobs's Life? [Last Updated On: August 17th, 2024] [Originally Added On: November 13th, 2011]
- Calendar: MIND Events in November and December [Last Updated On: August 17th, 2024] [Originally Added On: November 13th, 2011]
- He's No Gregory House--Which Is a Good Thing (preview) [Last Updated On: August 17th, 2024] [Originally Added On: November 20th, 2011]